AAV capsid engineering

| 1 min read

Learning from the last decade of gene therapies

Philip Wills, Chief Commercial Officer of the Cell & Gene Therapy Division at Catalent, reflects on how the gene therapy industry is evolving from early scientific breakthroughs to commercial maturity.

Video

A DNA vector background symbolizing gene therapy and the structure of the genetic code

| 6 min read

ByLuisa Torres, PhD

Overcoming the challenges of gene therapy

Experts discussed the major hurdles of AAV gene therapy, including immunogenicity, vector design, and AAV variability.

Articles

Page 1 of 1 - 2 Total Items

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

A researcher wearing a white lab coat and blue nitrile glove holds a tiny brown glass sample vial with a blue cap in front of an autosampler carousel on a HPLC laboratory analyzer.

Tell Us What You Know: Building robust chromatographic methods through inert hardware

Hear an expert perspective on the hidden variables affecting chromatographic methods and how to build more robust, reliable workflows.

Webinars

Researcher using a laptop with a digital DNA helix and molecular biology graphics overlaid, illustrating connected workflows for sequence design, data management, and therapeutic research.

Explained: How can molecular biology teams scale therapeutic design with connected workflows?

To keep pace with modern drug discovery, researchers need molecular biology approaches that can support complexity without slowing down the science.

Explainers

How can labs become truly sustainable?

Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.

Video

Learning from the last decade of gene therapies

Overcoming the challenges of gene therapy

Subscribe to our eNewsletters

Sponsored